Dasti JI, Gross U, Pohl S, Lugert R, Weig M & Schmidt-Ott R. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2007: 56: 833–837. JCR Impact factor 2.652
Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010; 300: 205–211. JCR Impact factor 4.173
Tareen AM, Dasti JI, Zautner AE, Gross U, Lugert R. Campylobacter jejuni proteins Cj0952c and Cj0951c affect chemotactic behaviour towards formic acid and are important for invasion of host cells. Microbiology 2010; 156:3123-35. JCR Impact factor 3.313
Tareen AM, Dasti JI, Zautner AE, Gross U, Lugert R. Sulphite. cytochrome c oxidoreductase deficiency in Campylobacter jejuni reduces motility, host cell adherence and invasion.Microbiology 2011; 157:1776-85. JCR Impact factor 3.313
Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, et al. Novel murine infection models provide deep insights into the “menage à trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011;6:e20953. JCR Impact factor 4.537
Din G, Malik S, Ali I, Ahmed S, Dasti JI. Prevelance of hepatitis C virus infection among thalassemia patients; a prospective from a multiethnic population of Pakistan. Asia Pac J Trop Med 2014; 7S1:S127-33. JCR impact factor 1.634
Ullah R W, Zahur AB, Latif A, Dasti JI, Irshad H, Afzal M, Rasheed T, Malik AR, Qureshi ZU. Detection of Peste des Petitis Ruminants viral RNA in Fecal Samples of Goats after an outbreak in Punjab province of Pakistan: a longitudinal study. Biomed Res Int 2016; 10.1155//1486824. JCR Impact factor 2.583
Dasti J.I. Zika virus infections: An overview of current scenario. Asian Pac J Trop Med 2016; 9(7) 621-625. JCR Impact factor 1.634
Rafaque Z, Dasti JI, Andrews SC. Draft genome sequence of multidrug resistant CTXM-15 Beta-lactamase producing uropathogenic E. coli isolates (ST131-025b-H30) from Pakistan exhibiting high potential virulence. J Glob Antimicrob Resist 2018; 15: 164-165. JCR Impact factor 2.022
Ali I, Dasti JI Chikungunya virus; an emerging arbovirus in Pakistan J Pak Med Assoc 2018; 68 (2), 252-257. JCR impact factor 0.409
Candida and Candidiasis today: Where are we, and where to go? (IFOCAN) 2005, Germany.
September 25-28, 2005. Annual Meeting of German Society for Hygiene and Microbiology and the Association for General and Applied Microbiology (VAAM), Germany.
Horizons in Molecular Biology. Decoding Nature: Hierarchy of Interactions. March 17-19, 2005. Goettingen, Germany.
October 4th 2006, Annual Meeting of German Society for Hygiene and Microbiology, Germany.
September, 2-5. 2007, 14th International workshop on Campylobacter, Helicobacter and Related Organisms, Zoonosis and public health, Rotterdam, the Netherlands.
October 30th - November 4 2007, Annual Meeting of German Society for Hygiene and Microbiology and Federation of European Microbiological Societies, Germany.
Annual scientific meeting Indonesian association of clinical microbiology 17-27 March 2008, Indonesia.
25th Symposium in Jena, 2-3, June 2008, Campylobacter infection, Germany (verbal presentation).
Flow-jo-Seminar 23. April, 2009, University of Freiburg, Germany
2010, WHO Symposium Hannover, Germany
March 26- 30, 2012, exploring the hidden potential of Microorganisms, German Academic Exchange Service (DAAD), and Pakistan.
February 22-23, 2013 10th Annual Conference of Infectious Diseases, Pakistan.
1st international conference on Biotechnology, 21-25th April 2013 at National Institute of Biotechnology and Genetic Engineering, Faisalabad Pakistan.
Poster and verbal presentation at 20th annual meeting by Medical Research Society of Pakistan, 25th May 2013 at Shawkat Khanum Memorial Cancer Hospital Lahore Pakistan.
Arranged a one-day symposium on Blood Donation “Donate to the deserving” at 8 October 2013, at Quaid-i-Azam University Islamabad.
Poster presentation at 11th annual conference on infectious disease, by Medical Microbiology and Infectious Diseases Society of Pakistan, at 14-15th March 2014 Hotel Margala, Islamabad.
Research data (Abstract submitted w/o participation) at 24th ECCMID (European Congress of Clinical Microbiology and Infectious diseases by ESCMID (European Society of Clinical Microbiology and Infectious Diseases) 10-13 th May 2014 at Barcelona Spain.
From 10-13th May 2014, New Challenges and Frontiers in infectious diseases, Islamabad, Pakistan (Posters & verbal presentations)
From 30 August to 4 September 2014, Session: CSI-02_Inflammation & disease (Poster), FEBS EMBO 2014 Conference, Paris, France
International Conference on Medical Biological and Pharmaceutical Sciences (ICMBPS), Berlin, Germany, November 29, 2015 (verbal presentations).
Poster presentation at first international conference on advancements in Biotechnology 30th -31st March 2016 at GC Women University Faisalabad.
International symposium on Nano medicines: Development, Testing, and Application possibilities organized by Nanotheranostics Lab, Nuclear Medicine Oncology and Radiotherapy Institute, Pakistan Atomic Energy Commission Islamabad on 1st March 2016.
One-day symposium on Burden of Antibiotic Resistance in Neonates Quaid-e-Azam University, Islamabad 29 March 2016
One-day symposium on the theme of Frontiers in Biology: From Discovery to Applications, Allama Iqbal Open University, Islamabad, 9 Jan 2017
Presenting poster of M.Phil. Research work entitled “Efficacy of ceftazidime and Trimethoprim on planktonic cells and biofilms of Uropathogenic E.coli” at 11th International Biennial Conference of Pakistan Society of Microbiology 18-20 Dec 2018.
Scientific Projects and Funding
· Commonwealth Research Support; 2019-2020; University of Reading, United Kingdom
· Commonwealth Research Support; 2016-2017; University of Reading, United Kingdom
· University Indigenous Research Fund, Year 2012-2018
· URF-QAU 2012-2018
· IPFP, HEC, Pakistan
· Deciphering Molecular Mechanisms of virulence of Campylobacter infection, University of Göttingen, Germany (Funded by DFG).
· To establish in vitro model airways to investigate the role of Toll-like receptors in mucociliary clearance and pneumococcal infection, University of Freiburg, Germany (Funded by DFG).
· To investigate Interplay of TLR2 and lipoproteins in group B streptococcal sepsis, University of Freiburg, Germany (Funded by NIH, USA in collaboration with Pasteur Institute, Paris, France
· Identification and characterization of Campylobacter jejuni factors relevant for the infection process, University of Göttingen, Germany (Funded by DFG, via GRK335).